Pitt’s McGowan Institute aims to study stem cells, 3D printers in space | TribLIVE.com

Pitt’s McGowan Institute aims to study stem cells, 3D printers in space

Paul Guggenheimer
Associated Press
International Space Station,

The University of Pittsburgh is teaming up with the International Space Station U.S. National Laboratory to study how the low-gravity environment of space can improve treatments for kidney disease, traumatic brain injury and juvenile diabetes.

Pitt’s McGowan Institute for Regenerative Medicine will collaborate with the ISSNL Industrial Biomedicine Program on research that will look at the unique behavior of stem cells in microgravity, 3D printers and other possible advancements.

Stem cells reproduce differently in low gravity, said William R. Wagner, director of the McGowan Institute. They don’t turn into other cells as quickly.

”They tend to stay more stem-like, more able to maintain a basic state before turning into other cells, which is useful,” Wagner said.

Microgravity could allow 3D printers to create complex tissue structures that are difficult to achieve in full gravity. It’s hard to print a complicated 3D structure in full gravity using squishy materials, Wagner said.

“When you do 3D printing in microgravity, you can work with weaker gel material. On Earth, if you print a gel-like material with 3D printing, it will tend to collapse. It will tend to spread out and make a puddle,” Wagner said. “In microgravity, it will retain the form that came out of the nozzle. As a result,you can work with softer materials and in many cases, the biological materials that we want to print are very soft, and we have to do things on Earth to stiffen them up so they don’t collapse.”

As part of the alliance, Pitt will develop Earth-based facilities on campus to advance research and meet with potential partners, while working with the ISSNL on flight opportunities to the orbiting laboratory. Richard Leach, the chief strategy officer for the space station’s lab, said the partnership will seek to develop biomedical products in space that could benefit humans on Earth.

“Part of the role of the ISS National Laboratory is to create and implement innovative strategies to enhance the research capacity of the orbiting laboratory, and we believe alliances like this will pave the way for future collaborations to advance the discoveries of space-based science,” Leach said.

Wagner said he’s excited about the chance to allow space-based science to immediately impact patients. If it is successful, more companies might be willing to invest in work being done in microgravity in low Earth orbit in five or 10 years.

“If we do that, then we have a much more robust platform, not just for medical research but other things like travel to the moon as far as materials development, and other areas of science that one wants to accomplish further out in space,” said Wagner.

Paul Guggenheimer is a Tribune-Review staff writer. You can contact Paul at 724-226-7706 or [email protected].

TribLIVE commenting policy

You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.